🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07293117
Recruiting Not applicable

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels

NCT07293117 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Not applicable
Started
2025-09-09
Last updated
2025-12-26

Condition(s) studied

Energy

Investigational drug(s) / intervention(s)

Heart & Soil Lifeblood

Heart & Soil Lifeblood: Lifeblood is an iron and blood-supporting supplement made of liver, spleen, and whole blood extract.

Study summary

This study explores how Heart \& Soil's Lifeblood impacts iron levels and energy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Hemochromatosis * Individuals with Severe Allergies * Pregnant or Nursing Women * Individuals with Gastrointestinal Disorders * Individuals on Iron-Related Medications * Individuals with Mental Health Disorders * Competitive Athletes

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York Recruiting

More Efforia, Inc trials in the USA

Other trials for the same condition

Morning Water Study Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07293117 on ClinicalTrials.gov ↗ ← All trials in the USA